SBT
- Product code
- SBT
- Device name
- Device To Detect Microbial Colonization Directly From Clinical Specimens.
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3967
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
A device to detect microbial colonization directly from clinical specimens is a qualitative in vitro diagnostic device intended for the detection and identification of microbial-associated targets from patients who are suspected of being colonized with a microbial pathogen and may present a risk of transmission to other patients and health care workers. This device is intended to aid in the detection of microbial colonizers for the prevention and control of infection in healthcare settings when used in conjunction with clinical and laboratory findings.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| DEN230092 | 2024-07-15 | Diasorin Molecular, LLC | Simplexa C. auris Direct, Simplexa C. auris Positive… | — |
Official FDA classification page: SBT
Classification and pathway per current FDA publications. Data from openFDA (CC0).